EP
GUTS icon

Essential Partners’s Fractyl Health GUTS Stock Holding History

Essential Partners’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-91
Closed -$147 – 2804
2025
Q2 		$147 Buy
+91
New +$147 ﹤0.01% 2013

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Essential Partners's GUTS Position: Q3 2025 in Review

Essential Partners sold out of Fractyl Health (GUTS) in Q3 2025, closing a stake of 91 shares — an estimated $147 sold.

Essential Partners first reported a position in GUTS in Q2 2025 and held it in 1 quarter. The position peaked at $147 in Q2 2025. 74 funds tracked by Wall St. Rank hold GUTS as of Q3 2025.

  • Essential Partners reported no remaining Fractyl Health position as of Q3 2025 after selling out during the quarter.
  • Essential Partners sold 91 Fractyl Health shares in Q3 2025, an estimated $147.
  • Essential Partners first reported a position in Fractyl Health in Q2 2025 and held it in 1 quarter.
  • Essential Partners's Fractyl Health position peaked at $147 in Q2 2025.
  • 74 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2025.

Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.